Literature DB >> 12917384

GCP II (NAALADase) inhibition suppresses mossy fiber-CA3 synaptic neurotransmission by a presynaptic mechanism.

Emilio R Garrido Sanabria1, Krystyna M Wozniak, Barbara S Slusher, Asaf Keller.   

Abstract

We tested the hypothesis that endogenous N-acetylaspartylglutamate (NAAG) presynaptically inhibits glutamate release at mossy fiber-CA3 synapses. For this purpose, we made use of 2-(3-mercaptopropyl)pentanedioic acid (2-MPPA), an inhibitor of glutamate carboxypeptidase II [GCP II; also known as N-acetylated alpha-linked acidic dipeptidase (NAALADase)], the enzyme that hydrolyzes NAAG into N-acetylaspartate and glutamate. Application of 2-MPPA (1-20 microM) had no effect on intrinsic membrane properties of CA3 pyramidal neurons recorded in vitro in whole cell current- or voltage-clamp mode. Bath application of 10 microM 2-MPPA suppressed evoked excitatory postsynaptic current (EPSC) amplitudes. Attenuation of EPSC amplitudes was accompanied by a significant increase in paired-pulse facilitation (50-ms interpulse intervals), suggesting that a presynaptic mechanism is involved. The group II metabotropic glutamate receptor (mGluR) antagonist 2S-2-amino-2-(1S,2S-2-carboxycyclopropyl-1-yl)-3-(xanth-9-y l) propanoic acid (LY341495) prevented the 2-MPPA-dependent suppression of EPSC amplitudes. 2-MPPA reduced the frequencies of TTX-insensitive miniature EPSCs (mEPSC), without affecting their amplitudes, further supporting a presynaptic action for GCP II inhibition. 2-MPPA-induced reduction of mEPSC frequencies was prevented by LY341495, reinforcing the role of presynaptic group II mGluR. Because GCP II inhibition is thought to increase NAAG levels, these results suggest that NAAG suppresses synaptic transmission at mossy fiber-CA3 synapses through presynaptic activation of group II mGluRs.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12917384      PMCID: PMC2810521          DOI: 10.1152/jn.00465.2003

Source DB:  PubMed          Journal:  J Neurophysiol        ISSN: 0022-3077            Impact factor:   2.714


  73 in total

1.  Multivesicular release from excitatory synapses of cultured hippocampal neurons.

Authors:  G Tong; C E Jahr
Journal:  Neuron       Date:  1994-01       Impact factor: 17.173

2.  Differential distribution of N-acetylaspartylglutamate and N-acetylaspartate immunoreactivities in rat forebrain.

Authors:  J R Moffett; M A Namboodiri
Journal:  J Neurocytol       Date:  1995-06

3.  Quantal mechanism of long-term potentiation in hippocampal mossy-fiber synapses.

Authors:  Z Xiang; A C Greenwood; E W Kairiss; T H Brown
Journal:  J Neurophysiol       Date:  1994-06       Impact factor: 2.714

4.  N-acetyl-aspartyl-glutamate (NAAG) elicits rapid increase in intraneuronal Ca2+ in vitro.

Authors:  M L Koenig; P M Rothbard; M A DeCoster; J L Meyerhoff
Journal:  Neuroreport       Date:  1994-05-09       Impact factor: 1.837

5.  Orientation selectivity of cortical neurons during intracellular blockade of inhibition.

Authors:  S Nelson; L Toth; B Sheth; M Sur
Journal:  Science       Date:  1994-08-05       Impact factor: 47.728

6.  Calcium dependence of the rate of exocytosis in a synaptic terminal.

Authors:  R Heidelberger; C Heinemann; E Neher; G Matthews
Journal:  Nature       Date:  1994-10-06       Impact factor: 49.962

7.  Comparative distribution of N-acetylaspartylglutamate and GAD67 in the cerebellum and precerebellar nuclei of the rat utilizing enhanced carbodiimide fixation and immunohistochemistry.

Authors:  J R Moffett; M Palkovits; A Namboodiri; J H Neale
Journal:  J Comp Neurol       Date:  1994-09-22       Impact factor: 3.215

8.  Quantal components of unitary EPSCs at the mossy fibre synapse on CA3 pyramidal cells of rat hippocampus.

Authors:  P Jonas; G Major; B Sakmann
Journal:  J Physiol       Date:  1993-12       Impact factor: 5.182

9.  Immunocytochemical distribution of N-acetylaspartylglutamate in the rat forebrain and glutamatergic pathways.

Authors:  G Tsai; B S Slusher; L Sim; J T Coyle
Journal:  J Chem Neuroanat       Date:  1993 Sep-Oct       Impact factor: 3.052

10.  Interactions between N-acetylaspartylglutamate and AMPA, kainate, and NMDA binding sites.

Authors:  H M Valivullah; J Lancaster; P M Sweetnam; J H Neale
Journal:  J Neurochem       Date:  1994-11       Impact factor: 5.372

View more
  30 in total

Review 1.  NAAG, NMDA receptor and psychosis.

Authors:  Richard Bergeron; Joseph T Coyle
Journal:  Curr Med Chem       Date:  2012       Impact factor: 4.530

2.  Impaired expression and function of group II metabotropic glutamate receptors in pilocarpine-treated chronically epileptic rats.

Authors:  Emilio R Garrido-Sanabria; Luis F Pacheco Otalora; Massoud F Arshadmansab; Berenice Herrera; Sebastian Francisco; Boris S Ermolinsky
Journal:  Brain Res       Date:  2008-09-10       Impact factor: 3.252

3.  Post-injury administration of NAAG peptidase inhibitor prodrug, PGI-02776, in experimental TBI.

Authors:  Jun-Feng Feng; Ken C Van; Gene G Gurkoff; Christina Kopriva; Rafal T Olszewski; Minsoo Song; Shifeng Sun; Man Xu; Joseph H Neale; Po-Wai Yuen; David A Lowe; Jia Zhou; Bruce G Lyeth
Journal:  Brain Res       Date:  2011-04-20       Impact factor: 3.252

Review 4.  Advances in understanding the peptide neurotransmitter NAAG and appearance of a new member of the NAAG neuropeptide family.

Authors:  Joseph H Neale; Rafal T Olszewski; Daiying Zuo; Karolina J Janczura; Caterina P Profaci; Kaleen M Lavin; John C Madore; Tomasz Bzdega
Journal:  J Neurochem       Date:  2011-07-01       Impact factor: 5.372

5.  High-field proton magnetic resonance spectroscopy reveals metabolic effects of normal brain aging.

Authors:  Janna L Harris; Hung-Wen Yeh; Russell H Swerdlow; In-Young Choi; Phil Lee; William M Brooks
Journal:  Neurobiol Aging       Date:  2014-01-23       Impact factor: 4.673

Review 6.  The therapeutic and diagnostic potential of the prostate specific membrane antigen/glutamate carboxypeptidase II (PSMA/GCPII) in cancer and neurological disease.

Authors:  James C Evans; Meenakshi Malhotra; John F Cryan; Caitriona M O'Driscoll
Journal:  Br J Pharmacol       Date:  2016-09-23       Impact factor: 8.739

7.  Oral administration of the NAALADase inhibitor GPI-5693 attenuates cocaine-induced reinstatement of drug-seeking behavior in rats.

Authors:  Xiao-Qing Peng; Jie Li; Eliot L Gardner; Charles R Ashby; Ajit Thomas; Krystyna Wozniak; Barbara S Slusher; Zheng-Xiong Xi
Journal:  Eur J Pharmacol       Date:  2009-10-31       Impact factor: 4.432

8.  Differential changes in mGlu2 and mGlu3 gene expression following pilocarpine-induced status epilepticus: a comparative real-time PCR analysis.

Authors:  Boris Ermolinsky; Luis F Pacheco Otalora; Massoud F Arshadmansab; Masoud M Zarei; Emilio R Garrido-Sanabria
Journal:  Brain Res       Date:  2008-06-07       Impact factor: 3.252

9.  Glutamate carboxypeptidase inhibition reduces the severity of chemotherapy-induced peripheral neurotoxicity in rat.

Authors:  Valentina A Carozzi; Alessia Chiorazzi; Annalisa Canta; Rena G Lapidus; Barbara S Slusher; Krystyna M Wozniak; Guido Cavaletti
Journal:  Neurotox Res       Date:  2009-09-15       Impact factor: 3.911

10.  Localization of NAAG-related gene expression deficits to the anterior hippocampus in schizophrenia.

Authors:  Subroto Ghose; Ronald Chin; Analysa Gallegos; Rosalinda Roberts; Joseph Coyle; Carol Tamminga
Journal:  Schizophr Res       Date:  2009-04-28       Impact factor: 4.939

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.